May 9, 2016 / 10:02 PM / 2 years ago

BRIEF-Aeterna Zentaris reports Q1 loss per share $0.37

May 9 (Reuters) - Aeterna Zentaris Inc :

* Aeterna Zentaris reports first quarter 2016 financial and operating results

* Q1 loss per share $0.37

* Aeterna Zentaris Inc says expected average monthly operating burn rate of approximately $2.8 million during remainder of 2016

* Aeterna zentaris inc says Zoptrex(tm) (Zoptarelin Doxorubicin) pivotal phase 3 clinical program on track for completion in Q3 2016

* Says Zoptrex(Tm) Licensee in China and related territories, Sinopharm A-Think pharmaceuticals Co., Ltd., scheduled to file IND in Q2 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below